Amway Malaysia Holdings Bhd (XKLS:6351) Research & Development: RM0 Mil (TTM As of Mar. 2026)


XKLS:6351 Amway Malaysia Holdings Bhd XKLS:6351
86 GF Score
Price RM4.56
GF Value RM4.84
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Amway Malaysia Holdings Bhd Research & Development?

Amway Malaysia Holdings Bhd XKLS:6351 -0.87% 86 Research & Development is RM0 Mil as of Mar. 2026. GuruFocus rates XKLS:6351 with a GF Score™ of 86/100 and a GF Value™ of RM4.84 (Fairly Valued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Amway Malaysia Holdings Bhd's Research & Development for the three months ended in Mar. 2026 was RM0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was RM0 Mil.

Amway Malaysia Holdings Bhd  (XKLS:6351) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Amway Malaysia Holdings Bhd Research & Development Related Terms

Amway Malaysia Holdings Bhd Research & Development Historical Data

* Premium members only.

The historical data trend for Amway Malaysia Holdings Bhd's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amway Malaysia Holdings Bhd Research & Development Chart

Amway Malaysia Holdings Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Amway Malaysia Holdings Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XKLS:6351
86GF Score
Amway Malaysia Holdings Bhd XKLS:6351
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amway Malaysia Holdings Bhd Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of RM0 Mil mean?
Amway Malaysia Holdings Bhd (XKLS:6351) has a Research & Development of RM0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Amway Malaysia Holdings Bhd and its competitors.
Is Amway Malaysia Holdings Bhd's Research & Development too high?
Amway Malaysia Holdings Bhd's current Research & Development is RM0 Mil. Overall, Amway Malaysia Holdings Bhd has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Amway Malaysia Holdings Bhd's Research & Development compare to CASY and WSM?
Amway Malaysia Holdings Bhd's Research & Development of RM0 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Retail - Cyclical company?
A good Research & Development depends on the Retail - Cyclical industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Amway Malaysia Holdings Bhd and its competitors. Amway Malaysia Holdings Bhd's current Research & Development is RM0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amway Malaysia Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Amway Malaysia Holdings Bhd (XKLS:6351) is currently considered Fairly Valued. The stock's GF Value™ is RM4.84, compared to a current price of RM4.56 — trading 5.8% below its estimated fair value. The current Research & Development is RM0 Mil. Amway Malaysia Holdings Bhd's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Amway Malaysia Holdings Bhd (XKLS:6351), the current Research & Development is RM0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Amway Malaysia Holdings Bhd (XKLS:6351) Overvalued in 2026?

Based on GuruFocus' analysis, Amway Malaysia Holdings Bhd stock appears to be undervalued. The current stock price of RM4.56 is trading 5.8% below its estimated GF Value™ of RM4.84. GuruFocus considers Amway Malaysia Holdings Bhd to be Fairly Valued.

Key valuation signals for XKLS:6351:

  • Research & Development: RM0 Mil
  • GF Value™: RM4.84 vs. price of RM4.56 (5.8% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the XKLS:6351 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Amway Malaysia Holdings Bhd Business Description

Address 28, Jalan, 51A/223, Petaling Jaya, SGR, MYS, 46100
Amway Malaysia Holdings Bhd is engaged in the distribution of consumer products under the Amway' trademark. The Group has only one business segment which is the distribution of consumer products principally under the Amway trademark. The company manufactures consumer products in the nutrition, beauty and home categories that are sold exclusively through Amway Business Owners. It has taken an initiative with Amway affiliates in Singapore, Thailand, Vietnam, Indonesia, Philippines, and Australia. The company also has an ARTISTRY SUPREME LX Regenerating Cream and Eye Cream under its skincare range and home categories that are sold exclusively through Amway Business Owners.
86GF Score

Get the complete analysis for XKLS:6351

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM4.56
Price
RM4.84
GF Value